UKIACR average (population) | UKIACR average (country) | England | Scotland | Wales | Northern Ireland | Republic of Ireland | |
---|---|---|---|---|---|---|---|
All invasive xnmsc | 25.8% | 23.7% | 26.5% | 26.2% | 20.3% | 25.7% | 19.8% |
All xnmsc 0-24 | 56.7% | 48.3% | 60.3% | 60.6% | 51.7% | 55.1% | 14.0% |
All xnmsc 25-59 | 39.4% | 37.0% | 40.4% | 43.2% | 33.5% | 40.9% | 27.1% |
All xnmsc 60-79 | 26.4% | 23.7% | 27.3% | 25.8% | 21.1% | 24.5% | 19.6% |
All xnmsc 80+ | 7.8% | 6.7% | 8.2% | 6.3% | 4.7% | 7.3% | 6.9% |
Haematology | 51.5% | 46.8% | 52.9% | 58.6% | 34.3% | 52.8% | 35.5% |
Head and Neck | 28.9% | 25.2% | 30.4% | 25.6% | 28.8% | 24.6% | 16.6% |
Lower GI | 31.5% | 28.5% | 32.5% | 30.0% | 24.7% | 28.5% | 26.8% |
Upper GI | 38.8% | 35.7% | 40.4% | 36.6% | 30.5% | 43.3% | 28.0% |
HPB | 23.6% | 21.3% | 24.7% | 19.9% | 15.8% | 26.5% | 19.5% |
Trachea, Bronchus & Lung | 28.1% | 24.9% | 29.4% | 23.4% | 24.2% | 24.0% | 23.4% |
Melanoma | 1.1% | 1.2% | 1.1% | 0.4% | 2.2% | 1.0% | 1.5% |
Breast | 31.7% | 31.0% | 31.9% | 33.3% | 25.9% | 33.4% | 30.6% |
Cervix | 34.7% | 35.1% | 34.6% | 43.0% | 26.0% | 49.4% | 22.6% |
Other Female Genitals | 29.2% | 28.6% | 29.3% | 33.9% | 22.2% | 32.4% | 25.2% |
Prostate | 3.2% | 3.1% | 3.2% | 5.6% | 3.7% | 2.6% | 0.4% |
Kidney | 8.4% | 8.0% | 8.6% | 4.0% | 9.7% | 8.0% | 9.9% |
Bladder | 29.7% | 25.2% | 31.1% | 28.7% | 22.9% | 28.2% | 15.0% |
Brain and CNS | 27.1% | 23.4% | 28.4% | 33.5% | 11.5% | 29.9% | 13.5% |
Thyroid & other endocrine glands | 4.7% | 4.6% | 4.8% | 4.7% | 5.6% | 4.6% | 3.5% |
CUP | 11.8% | 8.7% | 12.9% | 7.7% | 5.3% | 5.5% | 12.0% |
Other invasive cancer | 28.8% | 24.2% | 30.6% | 25.6% | 21.1% | 26.3% | 17.3% |
Breast in situ | 1.3% | 1.3% | 1.4% | 0.6% | 0.0% | 3.8% | 0.9% |
Cervix in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% |
Other tumours | 11.1% | 8.3% | 12.7% | 11.3% | 5.3% | 9.2% | 3.2% |
Non-Melanoma Skin Cancer | 0.1% | 0.4% | 0.1% | 0.6% | 0.2% | 0.9% | 0.1% |